Back to top

TG Therapeutics (TGTX) in Focus: Stock Moves 8.6% Higher

Read MoreHide Full Article

TG Therapeutics, Inc. (TGTX - Free Report) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 54.8% in the past one-month time frame.

The move came after the company reported that its final Phase2 Multiple Sclerosis data were accepted for presentation at the upcoming 34th Congress of ECTRIMS.

The company has seen two negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

TG Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.  

A better-ranked stock in the Medical – Products industry is ICU Medical, Inc. (ICUI - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is TGTX going up? Or down? Predict to see what others think: Up or Down

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


ICU Medical, Inc. (ICUI) - free report >>

TG Therapeutics, Inc. (TGTX) - free report >>

More from Zacks Tale of the Tape

You May Like